127 related articles for article (PubMed ID: 2848154)
21. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
22. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
23. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
[TBL] [Abstract][Full Text] [Related]
24. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
25. [Role of oxygen-derived free radicals for antitumor effects of intra-arterial injection with adriamycin].
Kokura S; Yoshikawa T; Kishi A; Tomii T; Tsujigiwa M; Yasuda M; Ichikawa H; Takano H; Takahashi S; Naito Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1711-4. PubMed ID: 2389960
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium.
Konno T
Cancer; 1990 Nov; 66(9):1897-903. PubMed ID: 2171752
[TBL] [Abstract][Full Text] [Related]
27. Experimental study of hepatic artery embolization: evaluation of various embolic materials.
Yamashita Y; Takahashi M; Fukushima S; Nishida M; Nakano M
Radiat Med; 1987; 5(3):75-82. PubMed ID: 2827239
[TBL] [Abstract][Full Text] [Related]
28. Hepatic parenchymal changes after the intraarterial injection of lipiodol in tumor-bearing rabbits.
Akashi Y; Koreeda C; Mizuno T; Inoue K; Kawa SK; Tanaka Y
Invest Radiol; 1993 Feb; 28(2):128-32. PubMed ID: 8383100
[TBL] [Abstract][Full Text] [Related]
29. Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier.
Nagamitsu A; Konno T; Oda T; Tabaru K; Ishimaru Y; Kitamura N
Eur J Cancer; 1998 Oct; 34(11):1764-9. PubMed ID: 9893666
[TBL] [Abstract][Full Text] [Related]
30. Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells.
Towu E; Al-Mufti R; Winslet M
J Pediatr Surg; 2004 Feb; 39(2):203-6; discussion 203-6. PubMed ID: 14966741
[TBL] [Abstract][Full Text] [Related]
31. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Kim YI; Lee KH; Jeong JM; Paeng JC
J Vasc Interv Radiol; 2004 Oct; 15(10):1121-8. PubMed ID: 15466799
[TBL] [Abstract][Full Text] [Related]
33. Intracavitary treatment of malignant ascitic carcinomatosis with oily anticancer agents in rats.
Kimura M; Konno T; Oda T; Maeda H; Miyauchi Y
Anticancer Res; 1993; 13(5A):1287-92. PubMed ID: 8239499
[TBL] [Abstract][Full Text] [Related]
34. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
Kalayci C; Johnson PJ; Raby N; Metivier EM; Williams R
J Hepatol; 1990 Nov; 11(3):349-53. PubMed ID: 1705275
[TBL] [Abstract][Full Text] [Related]
35. [Effect of lipiodol on MR images evaluation by dynamic MR imaging with intraarterial lipiodol injection in the rabbit VX-2 tumor].
Ito K; Fujita T; Homma Y; Sasai K; Nakanishi T
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):596-8. PubMed ID: 8392169
[TBL] [Abstract][Full Text] [Related]
36. Treatment of VX2 carcinoma implanted in the liver with arterial and intraperitoneal administration of oily anticancer agents.
Tabaru K; Konno T; Oda T; Nagamitsu A; Ishimaru Y; Kitamura N
Cancer Chemother Pharmacol; 2001; 47(2):149-54. PubMed ID: 11269741
[TBL] [Abstract][Full Text] [Related]
37. [The effects of lipiodol-hydroxyapatite nanoparticle on apoptosis, proliferation, and angiogenesis in hepatic tumor: experiment with rabbits].
Sun ZG; Chen XP; Huang ZY; Yang GH; Guan J; Hu DY; Mu LD; Xia XG; Li GP; Zhang WG; Li Z
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):409-13. PubMed ID: 17456384
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.
Johnson PJ; Kalayci C; Dobbs N; Raby N; Metivier EM; Summers L; Harper P; Williams R
J Hepatol; 1991 Jul; 13(1):120-7. PubMed ID: 1655867
[TBL] [Abstract][Full Text] [Related]
39. Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants.
Ogita S; Tokiwa K; Taniguchi H; Takahashi T
Cancer; 1987 Dec; 60(12):2886-90. PubMed ID: 2824018
[TBL] [Abstract][Full Text] [Related]
40. [Experimental studies on the effects of intralymphatic injection of lipiodol bleomycin in rabbits with VX2 carcinoma (author's transl)].
Hashimoto K
Kokubyo Gakkai Zasshi; 1981 Dec; 48(4):394-414. PubMed ID: 6174653
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
